HOME >> BIOLOGY >> NEWS
The UAB heads a European research project on proteases and pathological processes

A research group of the UAB Institute of Biotechnology and Biomedicine and the UAB Department of Biochemistry and Molecular Biology, directed by Francesc Xavier Avils, is the coordinator of a European project aimed at studying proteases with fluorescent molecules that allow their monitoring in healthy and pathological situations. Entitled "Chemical Genomics by Activity Monitoring of Proteases" (CAMP), the project was designed with the final objective of developing drugs to control proteases in inflammations, cardiovascular diseases, cancer and neurodegeneration.

The project has already begun and is being carried out by a consortium of research groups from different universities, small and medium sized enterprises, and a large pharmaceutical company. Although under UAB coordination, six other collaborating centres from Germany, Switzerland, Slovenia, United Kingdom and Denmark also work on the project. CAMP forms part of the European Union's Specific Targeted Catering Projects (STREP) and has a duration of three years.

Proteases are enzymes, or proteins that act as catalysts for other proteins when regulating many of the biological processes involved in blood coagulation, food processing, extracellular matrix renewing, etc. Without the regulation of protease activity, numerous pathologies can appear, such as cardiovascular, neuron and autoimmune diseases, inflammations, osteoporosis, arthritis and cancer.

The main objective of the CAMP project is to obtain information on the structure, activity and evolution of the proteases and its inhibitors (molecules that alter their functions) by monitoring their activities in situ and in vivo.

This will then help discover where the proteases that the drugs need to act on can be found. With this aim, the researchers have developed substrates with fluorescent molecules that will be attached to the proteases. This will allow them to monitor the proteases in tissue culture and live animals
'"/>

Contact: Manuel Morillas
Manuel.Morillas@bioinf.uab.es
34-935-811-231
Universitat Autonoma de Barcelona
17-Jul-2007


Page: 1 2

Related biology news :

1. 2 heads are better than 1: 2 dysfunctional DNA repair pathways kill tumor cells
2. Counting heads or measuring space?
3. If you flaunt it, youve got it: How red-heads top the pecking order
4. Carnegie Mellon rover heads to Atacama Desert for final mission in 3-year search for life
5. Romond heads up study and reduces breast cancer recurrence
6. University of Vermont heads translatlantic cardiovascular research network
7. European Science Foundations Forward Look reaches out beyond the endless frontiers
8. Journalists can register now for ECCO 14 -- the European Cancer Conference
9. Climate changes brews trouble for marine life in European Seas, Marine Board-ESF report says
10. Early Europeans unable to stomach milk
11. European launch of International Polar Year 2007-2008

Post Your Comments:
(Date:5/17/2013)... Societies for Experimental Biology (FASEB) released a new ... trends highlighting the devastating impact of sequestration on the ... follows a May 15th Senate Appropriations Committee hearing featuring ... the $1.6 billion cut the agency sustained in FY ... on the scientific community." , According to data ...
(Date:5/16/2013)... Access to Research Careers) Program has announced the ... Biology (SDB) 72nd Annual Meeting in Cancun, Mexico ... to promote the entry of students, postdoctorates and ... the basic science community and to encourage the ... Annual Meeting. , Awards are given to poster/platform ...
(Date:5/16/2013)... MIT may someday eliminate the need for patients ... blood-sugar levels and inject themselves with insulin. , ... in the body and respond by secreting the ... of pancreatic islet cells, which are destroyed in ... of system could ensure that blood-sugar levels remain ...
Breaking Biology News(10 mins):Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
(Date:5/17/2013)... , May 17, 2013  Insero Health, Inc., a ... in epilepsy and related neurological disorders, is today reporting ... lead compound INS001 in patients with drug-resistant epilepsy.  The ... Device Trials (AED) Xll meeting by Dr. ... Chairman of Insero,s Scientific Advisory Board.  In this study, ...
(Date:5/17/2013)... IAC Industries wants to share with you the ... to set up and furnish a research lab knowing that ... a year’s time. How does a company make choices in ... What is efficient and cost-effective? , The solution was ... The planners at DisperSol determined that the concept of modular ...
(Date:5/16/2013)... In late 2012, Dr. Sarah Hart, of Palm ... China about Appearance Medicine . Although Dr. Hart regularly ... trip to lecture in China, and quite a different experience ... to 12 and 7 million people respectively. Interest in cosmetic ... point in time. As Dr. Hart passed through the Fuzhou ...
(Date:5/16/2013)... SAN DIEGO , May 16, 2013  The ... the Association of Bioscience Financial Officers (ABFO) 2013 National Conference, ... will be held May 28-31 at the Hilton San ... finishing touches on this year,s conference and want to ... opportunity to attend," said Brandi Roberts ...
Breaking Biology Technology:Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4
Cached News: